Blockade of interleukin seventeen (IL-17A) with secukinumab in hospitalized COVID-19 patients – the BISHOP study

Author:

Resende Gustavo Gomes1ORCID,da Cruz Lage Ricardo1ORCID,Lobê Samara Quadros2,Medeiros Amanda Fonseca2,Costa e Silva Alessandra Dias2,Nogueira Sá Antônio Tolentino2ORCID,Oliveira Argenil José de Assis2ORCID,Sousa Denise2,Guimarães Henrique Cerqueira2ORCID,Gomes Isabella Coelho2,Souza Renan Pedra3ORCID,Aguiar Renato Santana3ORCID,Tunala Roberto4ORCID,Forestiero Francisco4ORCID,Bueno Filho Julio Silvio Souza5ORCID,Teixeira Mauro Martins6ORCID

Affiliation:

1. Rheumatology Unit, Hospital das Clínicas - Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil

2. Hospital Risoleta Tolentino Neves, Belo Horizonte, Brazil

3. Dept. of Genetics, Ecology and Evolution - UFMG, Belo Horizonte, Brazil

4. Novartis, São Paulo, Brazil

5. Department of Statistics, Universidade Federal de Lavras (UFLA), Lavras, Brazil

6. Department of Biochemistry and Immunology UFMG, Belo Horizonte, Brazil

Funder

Novartis Brazil

CNPq

MEC/CAPES

FINEP

The National Science and Technology Programs

MCTI/CNPQ/CAPES/FAPS

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3